The Feds just started charging drug company executives for price fixing
Advertisement
Flickr/Kiran Foster
Advertisement
Bloomberg is reporting that the former president and former CEO of Heritage Pharmaceuticals were both charged Monday.
In November, Bloomberg reported that Federal prosecutors may start bringing down charges regarding price fixing as part of a larger investigation into generic drugmakers. EpiPen-maker Mylan and Teva Pharmaceuticals are among the other companies under investigation.
This story is developing.
Advertisement
- I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
- One of the world's only 5-star airlines seems to be considering asking business-class passengers to bring their own cutlery
- Vodafone Idea FPO allotment – How to check allotment, GMP and more
- New study forecasts high chance of record-breaking heat and humidity in India in the coming months
- Gold plunges ₹1,450 to ₹72,200, silver prices dive by ₹2,300
- Strong domestic demand supporting India's growth: Morgan Stanley
- Global NCAP accords low safety rating to Bolero Neo, Amaze
- Agri exports fall 9% to $43.7 bn during Apr-Feb 2024 due to global, domestic factors